Sun He: Born in September, 1959, Chinese-American, professor, doctoral supervisor, drug research and management expert, clinical pharmacology and biopharmaceutics expert. He used to be the director of Tasly Holding Group Co., Ltd. and the chief scientist and presiding judge of quantitative pharmacology of the US Food and Drug Administration (FDA). He is currently the vice president of Tasly Holding Group Co., Ltd., the CEO of Science and Technology Innovation Group, the general manager of Tasly North America Pharmaceutical Co., Ltd., the general manager of Tianjin Yaang Pharmaceutical International Development Promotion Co., Ltd., the secretary-general of the World Federation of Traditional Chinese Medicine, the member of the judging committee, the judging expert of the "20 1 1 Plan" of the Ministry of Education, the member of the national overall expert group of major innovation projects, and the member of the national technical committee for standardization of traditional Chinese medicine. At the same time, he is a professor at Tianjin University, a doctoral supervisor, the head of the Department of Pharmaceutical Affairs Management, distinguished professor of Shanghai Institute of Life, China Academy of Sciences, a member of the Expert Steering Committee of Tianjin International Pharmaceutical Joint Research Institute, and distinguished professor of Nottingham University Medical College, UK.